daf-8
C. elegans
Smad protein daf-8
What the model saw
Gene: daf-8 Organism: Caenorhabditis elegans Known functions: Smad protein daf-8. DNA-binding transcription factor activity, RNA polymerase II-specific. I-SMAD binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding.
View unredacted entry
Smad protein daf-8. DNA-binding transcription factor activity, RNA polymerase II-specific. I-SMAD binding. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding.
Solver output
DAF-8 is a receptor-regulated SMAD (R-SMAD) that functions downstream of the DAF-7/TGF-β signaling pathway in C. elegans. In this pathway, DAF-8 (along with DAF-14) acts as a transcriptional activator that antagonizes the activity of DAF-3, a co-SMAD that promotes dauer formation and represses reproductive growth. DAF-8's DNA-binding transcription factor activity and I-SMAD binding capacity allow it to compete with or suppress DAF-3/DAF-5 transcriptional complexes. The TGF-β/DAF-7 branch intersects with the insulin/IGF-1 (DAF-2/DAF-16) pathway in regulating dauer entry and metabolic state; active DAF-8 signaling suppresses dauer formation and promotes normal development under favorable conditions. Loss of daf-8 leads to constitutive dauer formation, a state associated with extended lifespan, suggesting that DAF-8's normal function opposes the pro-longevity dauer program; however, in non-dauer adults, DAF-8 activity in the TGF-β pathway contributes to normal somatic maintenance and reproductive fitness, making its net longevity influence moderately pro-longevity in the context of nutrient-sensing pathway regulation.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted "pro_longevity" but the ground truth is "anti_longevity." The model's reasoning actually contains the key insight that loss of daf-8 leads to constitutive dauer formation (a state associated with extended lifespan), which implies daf-8 is anti-longevity — yet the model contradicts itself by concluding pro_longevity. The model incorrectly argues that DAF-8's role in "normal somatic maintenance" makes it net pro-longevity, ignoring that the GenAge classification is based on the empirical observation that loss-of-function of daf-8 extends lifespan (via dauer-like states), making it anti-longevity. The mechanistic reasoning is partially correct (DAF-8 is an R-SMAD in TGF-β/DAF-7 pathway opposing DAF-3), but the final conclusion drawn from that mechanism is wrong. The model essentially had the right mechanistic information but drew the wrong conclusion from it.
Raw API responses
solver
{
"reasoning": "DAF-8 is a receptor-regulated SMAD (R-SMAD) that functions downstream of the DAF-7/TGF-β signaling pathway in C. elegans. In this pathway, DAF-8 (along with DAF-14) acts as a transcriptional activator that antagonizes the activity of DAF-3, a co-SMAD that promotes dauer formation and represses reproductive growth. DAF-8's DNA-binding transcription factor activity and I-SMAD binding capacity allow it to compete with or suppress DAF-3/DAF-5 transcriptional complexes. The TGF-β/DAF-7 branch intersects with the insulin/IGF-1 (DAF-2/DAF-16) pathway in regulating dauer entry and metabolic state; active DAF-8 signaling suppresses dauer formation and promotes normal development under favorable conditions. Loss of daf-8 leads to constitutive dauer formation, a state associated with extended lifespan, suggesting that DAF-8's normal function opposes the pro-longevity dauer program; however, in non-dauer adults, DAF-8 activity in the TGF-β pathway contributes to normal somatic maintenance and reproductive fitness, making its net longevity influence moderately pro-longevity in the context of nutrient-sensing pathway regulation.",
"confidence": 0.72,
"key_pathways": [
"TGF-beta/DAF-7 signaling pathway",
"SMAD transcriptional regulation (DAF-8/DAF-14 vs DAF-3)",
"Dauer formation and insulin/IGF-1 pathway crosstalk"
],
"mechanism_class": "deregulated_nutrient_sensing",
"longevity_influence": "pro_longevity"
}advisor
{
"notes": "The model predicted \"pro_longevity\" but the ground truth is \"anti_longevity.\" The model's reasoning actually contains the key insight that loss of daf-8 leads to constitutive dauer formation (a state associated with extended lifespan), which implies daf-8 is anti-longevity — yet the model contradicts itself by concluding pro_longevity. The model incorrectly argues that DAF-8's role in \"normal somatic maintenance\" makes it net pro-longevity, ignoring that the GenAge classification is based on the empirical observation that loss-of-function of daf-8 extends lifespan (via dauer-like states), making it anti-longevity. The mechanistic reasoning is partially correct (DAF-8 is an R-SMAD in TGF-β/DAF-7 pathway opposing DAF-3), but the final conclusion drawn from that mechanism is wrong. The model essentially had the right mechanistic information but drew the wrong conclusion from it.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}